Jose Manuel Valdivielso Revilla

Betriu À; Farràs C; Abajo, M; Martinez-Alonso, M; Arroyo, D; Barbe, F; Buti, M; Lecube, A; Portero, M; Purroy, F; Torres, G; Valdivielso, JM; Fernandez, E

Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

Nefrologia 36 389-396. 01/07/2016.

[doi:10.1016/j.nefro.2016.02.008]

Valdivielso, J; Martinez-Alonso, M; Betriu, A; Gracia, M; Arroyo, D; Abajo, M; Salgueira, M; Gorriz, JL; Fernandez, E

THE NUMBER OF ARTERIAL TERRITORIES WITH ATHEROMA PLAQUE PREDICTS THE TIME FREE FROM CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. ANALYSIS OF THE NEFRONA STUDY AFTER 36 MONTHS OF FOLLOW-UP

NEPHROLOGY DIALYSIS TRANSPLANTATION 31 1429-1429. 01/05/2016.

Fernandez-Laso, V; Sastre, C; Valdivielso, JM; Betriu, A; Fernandez, E; Egido, J; Martin-Ventura, JL; Blanco-Colio, LM

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD

Clinical Journal Of The American Society Of Nephrology 11 413-422. 01/03/2016.

[doi:10.2215/CJN.07900715]

Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD

Clinical Journal Of The American Society Of Nephrology 11 287-296. 01/02/2016.

[doi:10.2215/CJN.01240215]

Jover, R; Bozic, M; Guzman, C; Sanchez-Campos, S; Garcia-Monzon, C; Valdivielso, JM

VITAMIN D RECEPTOR IS UP-REGULATED IN NAFLD HEPATOCYTES AND IS REQUIRED FOR HIGH FAT DIET-INDUCED STEATOSIS IN APOE(-/-) MICE LIVER

JOURNAL OF HEPATOLOGY 64 682-682. 01/01/2016.

[doi:10.1016/S0168-8278(16)01294-0]

Marco Mayayo MP; Martinez Alonso M; Valdivielso Revilla JM; Fernandez-Giraldez, E

A New Gender-Specific Formula to Estimate 24-Hour Urine Protein from Protein to Creatinine Ratio

Nephron 133 232-238. 01/01/2016.

[doi:10.1159/000447604]

Barrios C; Pascual J; Otero S; Soler MJ; Rodríguez E; Collado S; Faura A; Mojal S; Navarro-González JF; Betriu A; Fernandez E; Valdivielso JM; investigators of the NEFRONA study

Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease

Atherosclerosis 242 37-44. 01/09/2015.

[doi:10.1016/j.atherosclerosis.2015.06.048]

Bozic M; Álvarez Á; de Pablo C; Sanchez-Niño MD; Ortiz A; Dolcet X; Encinas M; Fernandez E; Valdivielso JM

Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development

PLOS ONE 10 -. 31/08/2015.

[doi:10.1371/journal.pone.0136863]

Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Mojal S; Fernández E; Soler MJ

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

NEPHROLOGY DIALYSIS TRANSPLANTATION 30 1176-1185. 01/07/2015.

[doi:10.1093/ndt/gfv025]

Gracia, M; Valdivielso, JM; Betriu, A; Abajo, M; Arroyo, D; Fernandez, ED

SUBCLINICAL ATHEROMATOSIS PROGRESSION AND ASSOCIATED RISK FACTORS IN CHRONIC KIDNEY DISEASE. THE NEFRONA STUDY

Atherosclerosis 241 14-15. 01/07/2015.

[doi:10.1016/j.atherosclerosis.2015.04.067]

Martin, M; Valls, J; Betriu, A; Fernandez, E; Valdivielso, JM

Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference

Atherosclerosis 241 264-270. 01/07/2015.

[doi:10.1016/j.atherosclerosis.2015.02.048]

Fernández-Laso V; Sastre C; Valdivielso JM; Fernández E; Martín-Ventura JL; Egido J; Blanco-Colio LM

Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases

Atherosclerosis 239 358-363. 01/04/2015.

[doi:10.1016/j.atherosclerosis.2015.01.040]